KNTE
Kinnate Biopharma Inc.
2.26
USD
This page is just a preview of the data found in TrendSpider’s full version
Kinnate Biopharma Inc. stock is up 83.74% since 30 days ago. The next earnings date is Mar 13, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 3 December’s closed higher than November. In the last 2 Unusual Options Trades, there were 2 PUTs.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 11 Dec 17:39 | 21 Jun, 2024 | 2.50 | 13457 | ||
| 11 Dec 20:31 | 21 Jun, 2024 | 2.50 | 13457 |
Kinnate Biopharma focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors.
